SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs > Ariad Pharmaceuticals, Inc. (ARIA)

That would be logical once the anecdotal reports

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
vidpok45 Member Profile
 
Followed By 21
Posts 3,581
Boards Moderated 0
Alias Born 06/15/10
160x600 placeholder
Advertisement
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/29/2015 7:45:09 AM
PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals "PR Newswire (US)" - 7/29/2015 7:35:00 AM
ARIAD to Receive up to $200 Million Through Iclusig Non-Dilutive Synthetic-Royalty Financing with PDL BioPharma "Business Wire" - 7/29/2015 7:35:00 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 7/28/2015 5:03:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/27/2015 4:40:19 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/24/2015 4:08:40 PM
ARIAD to Webcast Conference Call on Second Quarter 2015 Financial Results "Business Wire" - 7/22/2015 7:35:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/16/2015 5:41:07 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/16/2015 5:35:52 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/16/2015 5:27:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/16/2015 5:15:46 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/16/2015 5:13:36 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/16/2015 5:12:17 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/16/2015 5:09:35 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/16/2015 4:23:15 PM
Equity Coverage on Biotechnology -- Aeterna Zentaris, Ariad Pharma, AVEO Pharma, Aduro BioTech, and 22nd Century Group "PR Newswire (US)" - 7/16/2015 9:10:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 6/25/2015 4:08:06 PM
ARIAD rende noti i dati sulla sicurezza e l'efficacia a lungo termine di Ponatinib ottenuti da uno studio clinico Pace di fas... "Business Wire" - 6/17/2015 7:17:00 PM
ARIAD met à jour les données de tolérance et d'efficacité à long terme du ponatinib,provenant de l'essai clinique de pha... "Business Wire" - 6/16/2015 12:34:00 PM
ARIAD legt langfristige Sicherheits- und Wirksamkeitsdaten zu Ponatinib aus klinischer Phase-2-Studie PACE vor "Business Wire" - 6/14/2015 8:53:00 AM
ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial "Business Wire" - 6/12/2015 11:15:00 AM
Cancer Stocks: 2 to Sell, 1 to Buy "The Motley Fool" - 6/10/2015 10:05:06 AM
ARIAD and Paladin Announce Commercial Distribution Agreement for Iclusig (Ponatinib) in Canada "Business Wire" - 6/10/2015 7:35:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist